There is no doubt that we at Searcy Denney are seeing more and more cases of bone fractures that are occurring among women taking bisphosphonates to treat osteoporosis and osteopenia. But there may be even more cases out there that are going unreported. The authors of this article, William Ward […]
Category: Defective Drugs
You have to give it to Shirley Boles, 74 – she just doesn’t give up. Today concluded the third in a series of trials against drug giant, Merck, over the osteoporosis drug, Fosamax. Boles of Walton Beach, Florida, took the drug for nine years and developed jaw necrosis. On Tuesday, […]
A new Danish study in the journal, Calcified Tissue International, finds that a lower dose of osteoporosis drugs, also known as bisphosphonates, may actually represent a greater risk by about 50 percent of acute myocardial infarction, or clogging of the coronary vessels, when compared to a higher dose. Researchers from […]
The consumer advocacy group, Public Citizen, has filed a federal complaint against the U.S. Food and Drug Administration (FDA) to have the higher dose of the Alzheimer’s drug, Aricept, taken off the market because of the risk of fatal complications. The group made the first request 15 months ago and […]
In December, at the Joint meeting of the Reproductive Health Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee of the Food and Drug Administration, oral contraceptives containing drospirenone, approved since 2001, were discussed in detail. Drospirenone is a form of progestin, a synthetic hormone which is […]
Have you ever wondered how risky and dangerous drugs make it to market under the watchful eye of the U.S. Food and Drug Administration, charged with the responsibility of making sure they are safe and effective before they are released? The Journal of the American Medical Association tackles that question […]
AstraZeneca has agreed to pay $26 million to settle litigation involving the atypical antipsychotic, Seroquel. The South Carolina Attorney General had been after the company to reimburse state taxpayers for the off-label use of Seroquel. The company, along with other drugmakers, had challenged states that hire product liability attorneys on contingency […]
Physicians from American University in Lebanon published a case report regarding Pradaxa (dabigatran etexilate) that was published in the July 28, 2012, edition of the Journal of Thrombosis and Thrombolysis. In this article, the authors wrote about an 85 year old patient who developed shortness of breath, anemia, and white […]
[et_pb_section bb_built=”1″][et_pb_row][et_pb_column type=”4_4″][et_pb_text] Thirteen individuals have sued the makers of Nexium and Prevacid in California state court alleging the drug maker failed to adequately warn doctors and consumers that the acid reflux drugs cause bone loss and osteoporosis. Nexium, manufactured by AstraZeneca, and Prevacid, made by Takeda, are associated with […]
A federal judge has scheduled proceedings for the first of two test trials in the Actos litigation. The bellwether trials, as they are known, are set for November 3, 2014, and January 12, 2015 in the multidistrict litigation consolidated in the U.S. District Court for the Western District of Louisiana. […]
